OBiO Technology Raises ￥300M in Series C Round

According to VCBeat, recently, OBiO Technology (Shanghai) Co., Ltd. ("OBiO Technology") announced the completion of its Series C round of more than 300 million yuan, bringing the total amount raised to more than 600 million yuan in two rounds this year. The fresh round was led by Loyal Valley Capital, Morningside Group, Lingang Innovation Capital, Sherpa Venture Capital, Kunlun Capital, Jinpu Guotiao, and BioTrack Capital. Yikai Capital served as the company's financial advisor in the Pre-C and Series C financing.

Pan Oudong, the founder and chairman of OBiO Technology, said, "With the support of investors, we will continue to accelerate the globalization strategy and turn into a global CRO service center of recombinant viruses and the CDMO/CMO base for gene-based medicine."

Founded in March 2013, OBiO Technology is a domestic leading high-tech enterprise, which focuses on viral vector packaging service for both basic life science research and gene & cell therapy drug development and clinical preparation in China. Located at Shanghai International Medical Zone (SIMZ), the company can offer adeno-associated virus (AAV), lentivirus, adenovirus and retrovirus packaging services for experimental, preclinical and clinical research mainly in neuroscience, oncology, metabolism, cardiovascular disease.

LVC is a thematic, research-driven private equity firm that invests in middle-market companies positioned to benefit from the secular industry transformation in China. With AUM over US$2 billion, LVC focuses on four segments: New Consumer, Healthcare, Specialty Industrials, and Financial Services.

Founded in 2018 and is headquartered in Beijing, China, Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where the company has established robust portfolio sources, lasting value-adding cooperation and relationships, as well as mature all-cycle services with key resources.